Andrew Lane

Dana-Farber Cancer Institute

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Marlise Luskin

Dana-Farber Cancer Institute

UNITED STATES

View details

Daniel DeAngelo

Chief of the Division of Leukemia

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrew Lane

Research Interests

Explore related searches

Contact this professor

Articles (13)

PI3Kγ in leukemia: class IB PI3 kinase reemerges as a cancer-intrinsic target

Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCN

How I treat blastic plasmacytoid dendritic cell neoplasm

Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival

Leukemia circulation kinetics revealed through blood exchange method

Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations

Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia

AMPK activation induces immunogenic cell death in AML

DDX41: here, there…and everywhere

Genomics of PDGFR-rearranged hypereosinophilic syndrome

Peripheral blood CD3+ T‐cell gene expression biomarkers correlate with clinical frailty in patients with haematological malignancies

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm.

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.

Collaborators (2)

Marlise Luskin

Daniel DeAngelo

Make your next move.